Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Shares Outstanding (2016 - 2025)

CV Sciences' Shares Outstanding history spans 14 years, with the latest figure at $184.3 million for Q3 2025.

  • For Q3 2025, Shares Outstanding changed 0.0% year-over-year to $184.3 million; the TTM value through Sep 2025 reached $184.3 million, changed 0.0%, while the annual FY2024 figure was $184.3 million, 13.97% up from the prior year.
  • Shares Outstanding for Q3 2025 was $184.3 million at CV Sciences, roughly flat from $184.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $184.3 million in Q3 2024 and bottomed at $1000.0 in Q1 2022.
  • The 5-year median for Shares Outstanding is $161.7 million (2023), against an average of $150.3 million.
  • The largest annual shift saw Shares Outstanding increased 23.88% in 2023 before it changed 0.0% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $109.9 million in 2021, then surged by 38.34% to $152.1 million in 2022, then grew by 6.29% to $161.7 million in 2023, then grew by 13.97% to $184.3 million in 2024, then changed by 0.0% to $184.3 million in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Shares Outstanding are $184.3 million (Q3 2025), $184.3 million (Q2 2025), and $184.3 million (Q1 2025).